Welcome to Dwaey, specifically on Irbesartan page.
This medicine contains important and useful components, as it consists of
Irbesartan is available in the market in concentration.
Irbesartan
Before starting irbesartan, it is essential to consult a healthcare provider to ensure its safe and appropriate use. Important precautions include:
- Renal Impairment: Irbesartan should be used cautiously in patients with pre-existing renal impairment, as it may worsen kidney function or lead to further deterioration. Regular monitoring of kidney function (serum creatinine and blood urea nitrogen) is advised.
- Dehydration or Volume Depletion: In patients who are volume-depleted (due to diuretic use or fluid loss), irbesartan can cause a significant drop in blood pressure. A reduction in the dose of diuretics or careful monitoring is recommended when initiating treatment.
- Electrolyte Imbalances: Irbesartan can cause hyperkalemia (elevated potassium levels), so it is important to monitor serum potassium, especially in patients with renal impairment, diabetes, or those on potassium-sparing diuretics or potassium supplements.
- Pregnancy and Breastfeeding: Irbesartan is contraindicated during pregnancy, especially in the second and third trimesters, due to the risk of fetal harm, including renal failure, hypotension, and skull malformations. It is not recommended during breastfeeding, as it may pass into breast milk and harm the infant.
- Hepatic Impairment: Irbesartan should be used cautiously in patients with severe hepatic impairment, as it may increase the risk of side effects. Liver function tests should be monitored during treatment.
- Hypersensitivity: Any history of hypersensitivity or allergic reactions to irbesartan or other angiotensin II receptor blockers (ARBs) should prompt the patient to avoid this drug.
Irbesartan is primarily prescribed to manage high blood pressure (hypertension) and protect kidney function in individuals with diabetes. Its main therapeutic indications include:
- Hypertension: Irbesartan is commonly prescribed to manage high blood pressure in adults. It helps lower blood pressure, reducing the risk of heart attacks, strokes, and kidney problems.
- Diabetic Nephropathy: Irbesartan is used in patients with type 2 diabetes and hypertension to reduce the progression of diabetic nephropathy (kidney disease). It can help protect the kidneys from further damage by lowering blood pressure and reducing proteinuria (protein in the urine).
- Heart Failure: Although not typically first-line, irbesartan may be used in patients with heart failure, particularly those who cannot tolerate ACE inhibitors, to help reduce the symptoms and progression of heart failure.
Irbesartan is contraindicated in certain medical conditions to ensure patient safety:
- Pregnancy: Irbesartan is contraindicated during pregnancy, particularly in the second and third trimesters, due to the risk of fetal injury or death.
- Severe Renal Impairment: Patients with severe renal impairment (especially those with creatinine clearance <30 mL/min) should not use irbesartan, as it may exacerbate kidney dysfunction.
- Bilateral Renal Artery Stenosis: Irbesartan is contraindicated in patients with bilateral renal artery stenosis due to the risk of severe renal failure.
- Hypersensitivity: Irbesartan should not be used in individuals who have a known hypersensitivity to it or to any other angiotensin II receptor blockers (ARBs).
Irbesartan may cause side effects, ranging from mild to severe. Common and serious side effects include:
- Common Side Effects:
- Dizziness, lightheadedness, or fainting, especially when standing up quickly
- Fatigue or weakness
- Headache
- Nausea or abdominal pain
- Diarrhea
- Serious Side Effects:
- Hyperkalemia: Elevated potassium levels, which may cause muscle weakness, irregular heartbeats, or cardiac arrest, especially in patients with renal impairment or those taking potassium supplements.
- Hypotension: Significant low blood pressure, particularly after the first dose or in volume-depleted patients, can result in dizziness, fainting, or shock.
- Renal Dysfunction: Worsening kidney function, which may lead to acute kidney failure in severe cases, especially in patients with pre-existing kidney problems.
- Angioedema: Although rare, irbesartan may cause swelling of the face, lips, tongue, or throat, which can be life-threatening and requires immediate medical attention.
- Liver Toxicity: Although uncommon, liver function abnormalities may occur, and patients should be monitored for signs of jaundice or other symptoms of liver injury.
Patients should contact their healthcare provider if they experience any severe side effects, especially symptoms of angioedema or signs of kidney dysfunction.
3
Irbesartan works by blocking the action of angiotensin II, a hormone that causes blood vessels to constrict, leading to increased blood pressure. Its mechanism of action includes:
- Angiotensin II Receptor Blockade: Irbesartan specifically blocks the type 1 angiotensin II receptor (AT1 receptor). By inhibiting the binding of angiotensin II to this receptor, irbesartan causes blood vessels to relax and dilate, resulting in lower blood pressure.
- Reduced Aldosterone Secretion: By blocking angiotensin II, irbesartan also reduces the release of aldosterone, a hormone that causes the kidneys to retain sodium and water, thus helping to lower blood pressure and reduce fluid retention.
- Kidney Protection: In patients with diabetes, irbesartan helps reduce proteinuria (protein in the urine), which is a marker of kidney damage, thus protecting kidney function and preventing further decline in diabetic nephropathy.
The combination of these actions helps to lower blood pressure and reduce the risk of cardiovascular events, such as heart attack and stroke, while also protecting kidney function in vulnerable populations.
Irbesartan may interact with several drugs, increasing the risk of side effects or altering its efficacy:
- Diuretics: Co-administration with diuretics, especially potassium-sparing diuretics like spironolactone, may increase the risk of hyperkalemia (high potassium levels) and hypotension.
- Renal Impairment: When combined with other medications that affect kidney function (e.g., nonsteroidal anti-inflammatory drugs, or NSAIDs), irbesartan can further impair kidney function and may require dose adjustments.
- Lithium: Irbesartan can increase lithium levels in the blood, which could lead to lithium toxicity. Monitoring lithium levels is advised.
- Other Antihypertensive Agents: Irbesartan may have an additive effect when combined with other antihypertensive drugs, including ACE inhibitors, calcium channel blockers, or diuretics, resulting in excessive blood pressure lowering.
- Potassium Supplements: Irbesartan can increase potassium levels in the blood, so combining it with potassium supplements or potassium-sparing diuretics should be done with caution, with close monitoring of potassium levels.
Pregnancy category: 1st trimester, C; 2nd and 3rd trimesters, D
The usual starting dose of irbesartan for adults is 150 mg once daily. Based on the patient's response and tolerance, the dose may be adjusted as follows:
- Hypertension: The typical dose for managing high blood pressure is 150 mg once daily, with the possibility of increasing to 300 mg once daily for patients who require additional blood pressure control.
- Diabetic Nephropathy: In patients with type 2 diabetes and hypertension, the recommended starting dose is 150 mg once daily, with the potential for dose adjustment to 300 mg once daily.
Irbesartan is usually taken once a day, with or without food, but should be taken at the same time each day for consistency.
Irbesartan is not typically recommended for pediatric use, as its safety and efficacy have not been established in children. However, if used in children (under exceptional circumstances), healthcare providers must carefully adjust the dose based on the child’s weight and condition. The use of irbesartan in children under 18 should be done only under strict medical supervision and according to specialized guidelines.
---
As always, it is crucial for patients to consult their healthcare provider before starting irbesartan to ensure it is the right medication for their condition and to discuss any potential risks or interactions.
For patients with renal impairment, dose adjustments may be necessary:
- Mild to Moderate Renal Impairment (creatinine clearance ≥30 mL/min): No dose adjustment is generally required in patients with mild to moderate renal dysfunction.
- Severe Renal Impairment (creatinine clearance <30 mL/min): Irbesartan is contraindicated in patients with severe renal impairment or end-stage renal disease, as it can further worsen kidney function.
Close monitoring of renal function is recommended during treatment, especially in patients with any degree of renal impairment.
Not available in a medicine form yet